News | June 18, 2022
Stelis Biopharma’s two biologics manufacturing facilities receive EU cGMP accreditation
Both manufacturing facilities are based out of Benguluru, India
Both manufacturing facilities are based out of Benguluru, India
The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
The IDCF programme is being implemented from 13th June to 27th June, 2022 in the states/UTs and the goal is to attain zero child deaths due to childhood diarrhoea
Amarex Clinical Research guides its client to phase II of FDA trials
Cantourage introduces second Clever Leaves medical cannabis product to the German market
Subscribe To Our Newsletter & Stay Updated
